Retatrutide

🧬 

Retatrutide (Triple Agonist Peptide)

Category: Metabolic & Obesity Research

Purity: ≥ 99% (Research Grade)

🔬 

Research Overview

Retatrutide is an investigational triple-agonist peptide engineered to activate GLP-1, GIP, and glucagon receptors simultaneously.

Current studies indicate it may help regulate metabolism through a dual mechanism of reduced appetite and increased energy expenditure.

⚙️ 

Key Research Highlights

• May support advanced fat loss and improved body composition
• Promotes healthy glucose balance and insulin sensitivity
• Demonstrates potential to reduce liver fat and support metabolic health
• Encourages enhanced energy metabolism and lipid utilization
• Shows early promise for cardiometabolic benefits in ongoing trials

⚠️ 

Disclaimer

This material is supplied for laboratory and educational research only.

Not for human consumption, injection, or diagnostic use.

Retatrutide remains investigational and not FDA approved.